Coating formulations for scoring or cutting balloon catheters
View Patent ↗The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.
1. A scoring or cutting angioplasty balloon catheter carrying at least on a portion of its surface a therapeutically effective amount of the oxidation-insensitive drug paclitaxel; an amount of the lipophilic antioxidant nordihydroguaiaretic acid that will protect the paclitaxel from premature loss during delivery to an angioplasty site and that is 3-100% by weight of the weight of the paclitaxel; and an amount of a polymer that is 0-20% by weight of the paclitaxel.
2. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the amount of nordihydroguaiaretic acid is 5-100% by weight of the weight of the paclitaxel.
3. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the nordihydroguaiaretic acid load is up to 10 g/mm 2 of coated catheter surface.
4. The scoring or cutting angioplasty balloon catheter according to claim 1 which has been polymer-free coated with paclitaxel and nordihydroguaiaretic acid both together dissolved in tetrahydrofuran or a mixture of solvents containing more than 25% (v/v) tetrahydrofuran or each separately dissolved optionally selecting a different solvent for the nordihydroguaiaretic acid.
5. The scoring or cutting angioplasty balloon catheter according to claim 1 which has been polymer-free coated with paclitaxel and nordihydroguaiaretic acid both together dissolved in acetone or a mixture of solvents containing more than 25% (v/v) acetone or each separately dissolved optionally selecting a different solvent for the nordihydroguaiaretic acid.
6. The scoring or cutting angioplasty balloon catheter according to claim 1 , which has been polymer-free coated with paclitaxel and nordihydroguaiaretic acid in a way that the paclitaxel and the nordihydroguaiaretic acid are not homogeneously mixed.
7. The scoring or cutting angioplasty balloon catheter of claim 1 wherein the coating is polymer-free.
8. The scoring or cutting angioplasty balloon catheter of claim 1 wherein said catheter is a scoring balloon catheter.
9. The scoring or cutting angioplasty balloon catheter of claim 1 wherein said catheter is a cutting balloon catheter.
10. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the amount of nordihydroguaiaretic acid is 10-100% by weight of the weight of the paclitaxel.
11. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the amount of nordihydroguaiaretic acid is 20-100% by weight of the weight of the paclitaxel.
12. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the amount of nordihydroguaiaretic acid is 50-100% by weight of the weight of the paclitaxel.